Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
I-Mab Biopharma US Limited
I-Mab Biopharma US Limited
Pfizer
The Methodist Hospital Research Institute
Azienda Ospedaliero-Universitaria di Modena
Institut Paoli-Calmettes
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Chinese PLA General Hospital
Fudan University
State Scientific Centre of Coloproctology, Russian Federation
Dana-Farber Cancer Institute
UNICANCER
University of Florida
University of Leicester
Yonsei University
Institut Cancerologie de l'Ouest
West China Hospital
Chinese University of Hong Kong
Georgetown University
Vrinnevi Hospital
Light Sciences LLC
Light Sciences LLC
FeRx